<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36756116</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Tissue-resident memory T cells in renal autoimmune diseases.</ArticleTitle><Pagination><StartPage>1111521</StartPage><MedlinePgn>1111521</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1111521</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1111521</ELocationID><Abstract><AbstractText>The discovery of tissue-resident memory T cells (T<sub>RM</sub> cells) reinterpreted the potential of human tissue-specific immunity. Following T cell receptor (TCR) activation and clonal expansion, effector T cells migrate to peripheral tissues where they remain long-term and differentiate to T<sub>RM</sub> cells after antigen clearance. This allows for prompt immunological responses upon antigen re-encounter. In addition to their protective properties in acute infections, recent studies have revealed that T<sub>RM</sub> cells might lead to aggravation of autoimmune diseases, such as lupus nephritis (LN) and anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN). These diseases present as proliferative and crescentic glomerulonephritis (cGN), which is a life-threatening condition leading to end-stage renal disease (ESRD) if left untreated. A better understanding of renal T<sub>RM</sub> cells might lead to identifying new therapeutic targets for relapsing autoimmune diseases of the kidney. In this review, we summarize the current knowledge of renal T<sub>RM</sub> cells and discuss their potential pathophysiological roles in renal autoimmune diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ginsberg, Panzer and Asada.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ginsberg</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, Division of Translational Immunology, University Medical Hospital Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panzer</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, Division of Translational Immunology, University Medical Hospital Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asada</LastName><ForeName>Nariaki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, Division of Translational Immunology, University Medical Hospital Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019268">Antibodies, Antineutrophil Cytoplasmic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091246" MajorTopicYN="N">Memory T Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005921" MajorTopicYN="Y">Glomerulonephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019268" MajorTopicYN="N">Antibodies, Antineutrophil Cytoplasmic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANCA-associated glomerulonephritis</Keyword><Keyword MajorTopicYN="N">crescentic glomerulonephritis</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">renal autoimmune disease</Keyword><Keyword MajorTopicYN="N">tissue-resident memory T cell</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>2</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36756116</ArticleId><ArticleId IdType="pmc">PMC9899885</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1111521</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schenkel JM, Masopust D. Tissue-resident memory T cells. Immunity (2014) 41(6):886&#x2013;97. doi: 10.1016/j.immuni.2014.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.12.007</ArticleId><ArticleId IdType="pmc">PMC4276131</ArticleId><ArticleId IdType="pubmed">25526304</ArticleId></ArticleIdList></Reference><Reference><Citation>Asada N, Ginsberg P, Gagliani N, Mittr&#xfc;cker H-W, Panzer U. Tissue-resident memory T cells in the kidney. Semin Immunopathology (2022) 44(6):801&#x2013;11. doi: 10.1007/s00281-022-00927-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-022-00927-7</ArticleId><ArticleId IdType="pmc">PMC9708805</ArticleId><ArticleId IdType="pubmed">35411437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med (2021) 384(7):599&#x2013;609. doi: 10.1056/NEJMoa2023386</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023386</ArticleId><ArticleId IdType="pubmed">33596356</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (1998) 392(6673):245&#x2013;52. doi: 10.1038/32588</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/32588</ArticleId><ArticleId IdType="pubmed">9521319</ArticleId></ArticleIdList></Reference><Reference><Citation>Dornieden T, Sattler A, Pascual-Reguant A, Ruhm AH, Thiel LG, Bergmann YS, et al. . Signatures and specificity of tissue-resident lymphocytes identified in human renal peritumor and tumor tissue. J Am Soc Nephrol (2021) 32(9):2223&#x2013;41. doi: 10.1681/ASN.2020101528</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020101528</ArticleId><ArticleId IdType="pmc">PMC8729844</ArticleId><ArticleId IdType="pubmed">34074699</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, et al. . Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol (2015) 194(5):2059&#x2013;63. doi: 10.4049/jimmunol.1402256</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402256</ArticleId><ArticleId IdType="pubmed">25624457</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Bergsbaken T, Edelblum KL. The multifunctional nature of CD103 (&#x3b1;E&#x3b2;7 integrin) signaling in tissue-resident lymphocytes. Am J Physiol Cell Physiol (2022) 323(4):C1161&#x2013;c1167. doi: 10.1152/ajpcell.00338.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00338.2022</ArticleId><ArticleId IdType="pmc">PMC9576162</ArticleId><ArticleId IdType="pubmed">36036450</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Putten C, Remmerswaal EBM, Terpstra ML, van der Bom ND, Kers J, Ten Berge IJM, et al. . CD8 and CD4 T cell populations in human kidneys. Cells (2021) 10(2):288. doi: 10.3390/cells10020288</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020288</ArticleId><ArticleId IdType="pmc">PMC7912772</ArticleId><ArticleId IdType="pubmed">33535505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Mishra S, Demel EL, Liu Y, Zhang N. TGF-beta controls the formation of kidney-resident T cells via promoting effector T cell extravasation. J Immunol (2017) 198(2):749&#x2013;56. doi: 10.4049/jimmunol.1601500</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601500</ArticleId><ArticleId IdType="pmc">PMC5225110</ArticleId><ArticleId IdType="pubmed">27903738</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V, et al. . IL-15-Independent maintenance of tissue-resident and boosted effector memory CD8 T cells. J Immunol (2016) 196(9):3920&#x2013;6. doi: 10.4049/jimmunol.1502337</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502337</ArticleId><ArticleId IdType="pmc">PMC5145194</ArticleId><ArticleId IdType="pubmed">27001957</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol (2015) 13(5):269&#x2013;84. doi: 10.1038/nrmicro3432</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3432</ArticleId><ArticleId IdType="pmc">PMC4457377</ArticleId><ArticleId IdType="pubmed">25853778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: Cytomegalovirus infection. Am J Kidney Dis (2016) 68(6):e35&#x2013;6. doi: 10.1053/j.ajkd.2016.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2016.10.008</ArticleId><ArticleId IdType="pubmed">27884284</ArticleId></ArticleIdList></Reference><Reference><Citation>Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis &amp; clinical management. Indian J Med Res (2014) 139(2):195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001330</ArticleId><ArticleId IdType="pubmed">24718393</ArticleId></ArticleIdList></Reference><Reference><Citation>Parga-Vidal L, van Aalderen MC, Stark R, van Gisbergen K. Tissue-resident memory T cells in the urogenital tract. Nat Rev Nephrol (2022) 18(4):209&#x2013;23. doi: 10.1038/s41581-021-00525-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00525-0</ArticleId><ArticleId IdType="pubmed">35079143</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart BJ, Ferdinand JR, Young MD, Mitchell TJ, Loudon KW, Riding AM, et al. . Spatiotemporal immune zonation of the human kidney. Science (2019) 365(6460):1461&#x2013;6. doi: 10.1126/science.aat5031</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat5031</ArticleId><ArticleId IdType="pmc">PMC7343525</ArticleId><ArticleId IdType="pubmed">31604275</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JG, Na M, Kim MG, Park SH, Lee HJ, Kim DK, et al. . Immune cell composition in normal human kidneys. Sci Rep (2020) 10(1):15678. doi: 10.1038/s41598-020-72821-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72821-x</ArticleId><ArticleId IdType="pmc">PMC7515917</ArticleId><ArticleId IdType="pubmed">32973321</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs CF, Reimers D, Zhao Y, Paust HJ, Bartsch P, Nu&#xf1;ez S, et al. . Pathogen-induced tissue-resident memory T(H)17 (T(RM)17) cells amplify autoimmune kidney disease. Sci Immunol (2020) 5(50):eaba4163. doi: 10.1126/sciimmunol.aba4163</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aba4163</ArticleId><ArticleId IdType="pubmed">32769171</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke A, Tiegs G, Neumann K. Pathogenic T-cell responses in immune-mediated glomerulonephritis. Cells (2022) 11(10):1625. doi: 10.3390/cells11101625</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11101625</ArticleId><ArticleId IdType="pmc">PMC9139939</ArticleId><ArticleId IdType="pubmed">35626662</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeets B, Uhlig S, Fuss A, Mooren F, Wetzels JF, Floege J, et al. . Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 20(12):2604&#x2013;15. doi: 10.1681/ASN.2009010122</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009010122</ArticleId><ArticleId IdType="pmc">PMC2794233</ArticleId><ArticleId IdType="pubmed">19917779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Guo C, Li X, Huang Y, Li M, Zhang T, et al. . JAK/STAT signaling controls the fate of CD8(+)CD103(+) tissue-resident memory T cell in lupus nephritis. J Autoimmun (2020) 109:102424. doi: 10.1016/j.jaut.2020.102424</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102424</ArticleId><ArticleId IdType="pubmed">32085893</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, Avery L, Menk AV, Gordon RA, Smita S, Kane LP, et al. . Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest (2018) 128(11):4884&#x2013;97. doi: 10.1172/JCI120859</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI120859</ArticleId><ArticleId IdType="pmc">PMC6205402</ArticleId><ArticleId IdType="pubmed">30130253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabs DA, Burek CL, Hu Q, Kuppers RC, Lee B, Prendergast RA. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol (1992) 141(2):496&#x2013;507. doi: 10.1016/0008-8749(92)90166-M</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-8749(92)90166-M</ArticleId><ArticleId IdType="pubmed">1576659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 179(4):1137&#x2013;43. doi: 10.1084/jem.179.4.1137</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.4.1137</ArticleId><ArticleId IdType="pmc">PMC2191453</ArticleId><ArticleId IdType="pubmed">7908320</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino R, Fossati L, Iwamoto M, Takahashi S, Lemoine R, Ibnou-Zekri N, et al. . Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun (1995) 8(1):33&#x2013;45. doi: 10.1006/jaut.1995.0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1995.0003</ArticleId><ArticleId IdType="pubmed">7734035</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Fueyo A, Bradley SJ, Tsokos GC. T Cells in systemic lupus erythematosus. Curr Opin Immunol (2016) 43:32&#x2013;8. doi: 10.1016/j.coi.2016.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.09.001</ArticleId><ArticleId IdType="pmc">PMC5125867</ArticleId><ArticleId IdType="pubmed">27636649</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. . The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol (2019) 20(7):902&#x2013;14. doi: 10.1038/s41590-019-0398-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0398-x</ArticleId><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol (2016) 16(2):79&#x2013;89. doi: 10.1038/nri.2015.3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.3</ArticleId><ArticleId IdType="pubmed">26688350</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, et al. . Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature (2006) 442(7100):299&#x2013;302. doi: 10.1038/nature04882</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04882</ArticleId><ArticleId IdType="pubmed">16855590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, et al. . The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol (2013) 14(12):1294&#x2013;301. doi: 10.1038/ni.2744</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2744</ArticleId><ArticleId IdType="pubmed">24162776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, et al. . Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature (2017) 543(7644):252&#x2013;6. doi: 10.1038/nature21379</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21379</ArticleId><ArticleId IdType="pmc">PMC5509051</ArticleId><ArticleId IdType="pubmed">28219080</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor CT, Scholz CC. The effect of HIF on metabolism and immunity. Nat Rev Nephrol (2022) 18(9):573&#x2013;87. doi: 10.1038/s41581-022-00587-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00587-8</ArticleId><ArticleId IdType="pmc">PMC9208707</ArticleId><ArticleId IdType="pubmed">35726016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, et al. . Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U.S.A. (2012) 109(18):7037&#x2013;42. doi: 10.1073/pnas.1202288109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1202288109</ArticleId><ArticleId IdType="pmc">PMC3344960</ArticleId><ArticleId IdType="pubmed">22509047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 10(5):524&#x2013;30. doi: 10.1038/ni.1718</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1718</ArticleId><ArticleId IdType="pubmed">19305395</ArticleId></ArticleIdList></Reference><Reference><Citation>Owczarczyk Saczonek A, Krajewska-W&#x142;odarczyk M, Kasprowicz-Furma&#x144;czyk M, Placek W. Immunological memory of psoriatic lesions. Int J Mol Sci (2020) 21(2):625. doi: 10.3390/ijms21020625</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21020625</ArticleId><ArticleId IdType="pmc">PMC7014148</ArticleId><ArticleId IdType="pubmed">31963581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet (9957) 2014:1878&#x2013;88:384. doi: 10.1016/S0140-6736(14)60128-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60128-8</ArticleId><ArticleId IdType="pubmed">24881804</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365(22):2110&#x2013;21. doi: 10.1056/NEJMra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: Core curriculum 2020. Am J Kidney Dis (2020) 76(2):265&#x2013;81. doi: 10.1053/j.ajkd.2019.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.10.017</ArticleId><ArticleId IdType="pubmed">32220510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol (2013) 24(9):1357&#x2013;66. doi: 10.1681/ASN.2013010026</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013010026</ArticleId><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int (1990) 37(1):100&#x2013;9. doi: 10.1038/ki.1990.14</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1990.14</ArticleId><ArticleId IdType="pubmed">1967662</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzi L, Merville P, Demini&#xe8;re C, Moreau JF, Combe C, Pellegrin JL, et al. . Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum (2007) 56(7):2362&#x2013;70. doi: 10.1002/art.22654</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22654</ArticleId><ArticleId IdType="pubmed">17599764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Wang M, Zhang J, Feng X, Liu Z, Cheng Z. Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis. Int Immunopharmacol (2021) 99:107877. doi: 10.1016/j.intimp.2021.107877</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107877</ArticleId><ArticleId IdType="pubmed">34217995</ArticleId></ArticleIdList></Reference><Reference><Citation>Smita S, Chikina M, Shlomchik MJ, Tilstra JS. Heterogeneity and clonality of kidney-infiltrating T cells in murine lupus nephritis. JCI Insight (2022) 7(8):e156048. doi: 10.1172/jci.insight.156048</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.156048</ArticleId><ArticleId IdType="pmc">PMC9089785</ArticleId><ArticleId IdType="pubmed">35271505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugahara M, Tanaka T, Nangaku M. Hypoxia-inducible factor and oxygen biology in the kidney. Kidney360 (2020) 1(9):1021&#x2013;31. doi: 10.34067/KID.0001302020</Citation><ArticleIdList><ArticleId IdType="doi">10.34067/KID.0001302020</ArticleId><ArticleId IdType="pmc">PMC8815601</ArticleId><ArticleId IdType="pubmed">35369554</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata H, Matsumura R, Koyama A, Sugiyama T, Sueishi M, Shibuya K, et al. . T Cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Arthritis Rheum (2002) 46(8):2141&#x2013;7. doi: 10.1002/art.10432</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10432</ArticleId><ArticleId IdType="pubmed">12209519</ArticleId></ArticleIdList></Reference><Reference><Citation>Massengill SF, Goodenow MM, Sleasman JW. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am J Kidney Dis (1998) 31(3):418&#x2013;26. doi: 10.1053/ajkd.1998.v31.pm9506678</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.1998.v31.pm9506678</ArticleId><ArticleId IdType="pubmed">9506678</ArticleId></ArticleIdList></Reference><Reference><Citation>Winchester R, Wiesendanger M, Zhang HZ, Steshenko V, Peterson K, Geraldino-Pardilla L, et al. . Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell beta-chain clonotypes in progressive lupus nephritis. Arthritis Rheum (2012) 64(5):1589&#x2013;600. doi: 10.1002/art.33488</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.33488</ArticleId><ArticleId IdType="pmc">PMC3297718</ArticleId><ArticleId IdType="pubmed">22130908</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdirama D, Tesch S, Grie&#xdf;bach AS, Spee-Mayer von C, Humrich JY, Stervbo U, et al. . Nuclear antigen-reactive CD4(+) T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys. Kidney Int (2021) 99(1):238&#x2013;46. doi: 10.1016/j.kint.2020.05.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.051</ArticleId><ArticleId IdType="pubmed">32592813</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolff S, Abdulahad WH, Dijk van MC, Limburg PC, Kallenberg CG, Bijl M. Urinary T cells in active lupus nephritis show an effector memory phenotype. Ann Rheum Dis (2010) 69(11):2034&#x2013;41. doi: 10.1136/ard.2009.124636</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.124636</ArticleId><ArticleId IdType="pubmed">20472588</ArticleId></ArticleIdList></Reference><Reference><Citation>Enghard P, Rieder C, Kopetschke K, Klocke JR, Undeutsch R, Biesen R, et al. . Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response. Ann Rheum Dis (2014) 73(1):277&#x2013;83. doi: 10.1136/annrheumdis-2012-202784</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202784</ArticleId><ArticleId IdType="pubmed">23475982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolo M, Baumgart S, Durek P, Peddinghaus A, Mei H, Rose T, et al. . Deep phenotyping of urinary leukocytes by mass cytometry reveals a leukocyte signature for early and non-invasive prediction of response to treatment in active lupus nephritis. Front Immunol (2020) 11:256. doi: 10.3389/fimmu.2020.00256</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00256</ArticleId><ArticleId IdType="pmc">PMC7105605</ArticleId><ArticleId IdType="pubmed">32265898</ArticleId></ArticleIdList></Reference><Reference><Citation>Geetha D, Jefferson JA. ANCA-associated vasculitis: Core curriculum 2020. Am J Kidney Dis (2020) 75(1):124&#x2013;37. doi: 10.1053/j.ajkd.2019.04.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.04.031</ArticleId><ArticleId IdType="pubmed">31358311</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. . 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum (2013) 65(1):1&#x2013;11. doi: 10.1002/art.37715</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37715</ArticleId><ArticleId IdType="pubmed">23045170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. . ANCA-associated vasculitis. Nat Rev Dis Primers (2020) 6(1):71. doi: 10.1038/s41572-020-0204-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0204-y</ArticleId><ArticleId IdType="pubmed">32855422</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, et al. . Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol (2017) 69(5):1054&#x2013;66. doi: 10.1002/art.40034</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40034</ArticleId><ArticleId IdType="pmc">PMC5434905</ArticleId><ArticleId IdType="pubmed">28029757</ArticleId></ArticleIdList></Reference><Reference><Citation>Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, et al. . Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. J Autoimmun (2020) 106:102306. doi: 10.1016/j.jaut.2019.102306</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102306</ArticleId><ArticleId IdType="pmc">PMC6930338</ArticleId><ArticleId IdType="pubmed">31383567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DP, McInnis EA, Wu EY, Stember KG, Hogan SL, Hu Y, et al. . Immunological interaction of HLA-DPB1 and proteinase 3 in ANCA vasculitis is associated with clinical disease activity. J Am Soc Nephrol (2022) 33(8):1517&#x2013;27. doi: 10.1681/ASN.2021081142</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021081142</ArticleId><ArticleId IdType="pmc">PMC9342628</ArticleId><ArticleId IdType="pubmed">35672132</ArticleId></ArticleIdList></Reference><Reference><Citation>Shochet L, Kitching AR. Identifying antigen-specific T cells in ANCA-associated vasculitis: A glimpse of the future? J Am Soc Nephrol (2022) 33(8):1435&#x2013;7. doi: 10.1681/ASN.2022060668</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2022060668</ArticleId><ArticleId IdType="pmc">PMC9342648</ArticleId><ArticleId IdType="pubmed">35906086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol (2019) 15(2):91&#x2013;101. doi: 10.1038/s41584-018-0145-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0145-y</ArticleId><ArticleId IdType="pubmed">30542206</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan KM, Lo CY, Summers SA, Elgass KD, McMillan PJ, Longano A, et al. . Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int (2015) 88(5):1030&#x2013;46. doi: 10.1038/ki.2015.202</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.202</ArticleId><ArticleId IdType="pubmed">26176828</ArticleId></ArticleIdList></Reference><Reference><Citation>Disteldorf EM, Krebs CF, Paust HJ, Turner JE, Nouailles G, Tittel A, et al. . CXCL5 drives neutrophil recruitment in TH17-mediated GN. J Am Soc Nephrol (2015) 26(1):55&#x2013;66. doi: 10.1681/ASN.2013101061</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013101061</ArticleId><ArticleId IdType="pmc">PMC4279732</ArticleId><ArticleId IdType="pubmed">24904089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HG, Cho MZ, Choi JM. Bystander CD4(+) T cells: crossroads between innate and adaptive immunity. Exp Mol Med (2020) 52(8):1255&#x2013;63. doi: 10.1038/s12276-020-00486-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00486-7</ArticleId><ArticleId IdType="pmc">PMC8080565</ArticleId><ArticleId IdType="pubmed">32859954</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, et al. . 2019 update of the joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis (2020) 79(6):713&#x2013;23. doi: 10.1136/annrheumdis-2020-216924</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-216924</ArticleId><ArticleId IdType="pubmed">32220834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. . 2021 American college of Rheumatology/Vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol (2021) 73(8):1366&#x2013;83. doi: 10.1002/art.41773</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41773</ArticleId><ArticleId IdType="pubmed">34235894</ArticleId></ArticleIdList></Reference><Reference><Citation>Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, et al. . Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med (2020) 383(12):1117&#x2013;28. doi: 10.1056/NEJMoa2001180</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001180</ArticleId><ArticleId IdType="pubmed">32937045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, et al. . Targeting CD38 with daratumumab in refractory systemic lupus erythematosus. N Engl J Med (2020) 383(12):1149&#x2013;55. doi: 10.1056/NEJMoa2023325</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023325</ArticleId><ArticleId IdType="pubmed">32937047</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Gracht ETI, Behr FM, Arens R. Functional heterogeneity and therapeutic targeting of tissue-resident memory T cells. Cells (2021) 10(1):164. doi: 10.3390/cells10010164</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010164</ArticleId><ArticleId IdType="pmc">PMC7829818</ArticleId><ArticleId IdType="pubmed">33467606</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond JM, Strassner JP, Zapata L, Jr, Garg M, Riding RL, Refat MA, et al. . Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Sci Transl Med (2018) 10(450). doi: 10.1126/scitranslmed.aam7710</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aam7710</ArticleId><ArticleId IdType="pmc">PMC6495055</ArticleId><ArticleId IdType="pubmed">30021889</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra P, Santamaria P. Antigen-specific therapeutic approaches for autoimmunity. Nat Biotechnol (2019) 37(3):238&#x2013;51. doi: 10.1038/s41587-019-0015-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0015-4</ArticleId><ArticleId IdType="pubmed">30804535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>